<DOC>
	<DOC>NCT00367939</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy of valsartan plus amlodipine in hypertensive patients not responding to treatment with ACE inhibitor plus calcium channel blocker</brief_summary>
	<brief_title>Efficacy and Safety of the Combination of Valsartan Plus Amlodipine in Hypertensive Patients Not Adequately Responding to the Combination Therapy With Ramipril Plus Felodipine</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<mesh_term>Felodipine</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Male or female patients (18 years or older) Females must be either postmenopausal for one year, surgically sterile or using effective contraceptive methods (e.g. barrier method with spermicide, intrauterine device, hormonal contraceptives). Patients with moderate essential hypertension (WHO II) Severe hypertension Pregnant or nursing women Treated hypertensive patients with controlled hypertension under current therapy (MSDBP &lt; 90 mmHg and MSSBP &lt; 140 mmHg) A history of cardiovascular disease, including angina pectoris, myocardial infarction, coronary artery bypass graft, percutaneous transluminal coronary angioplasty, transient ischemic attack, stroke, and heart failure NYHA II IV Other protocoldefined exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Hypertension</keyword>
</DOC>